Â鶹AV

Home

Stephanie Wong

Academic title(s): 
  • Assistant Professor, Â鶹AV, Department of Surgery and Oncology
  • Clinician Researcher, Lady Davis Institute for Medical Research
Stephanie Wong
Contact Information
Phone: 
(514) 340-8222, Ext. 24210
Location: 
Jewish General Hospital (JGH)
Office: 
E713
Hospital title: 
Attending Surgeon, Jewish General Hospital
Director, JGH Stroll Cancer Prevention Centre High Risk Breast Clinic
Degree(s): 

MD, MPH

Awards, honours, and fellowships: 

2021 FRQS Clinical Research Scholars (Junior 1)

Current research: 

Clinical epidemiology; Research with large population-level databases; Cancer prevention in high-risk patient populations; Surgical decision making

Clinical Interests: 

Breast cancer; Hereditary breast cancer; Screening and prevention in women at elevated breast cancer risk

Language(s) spoken: 
English
French
Biography: 

Stephanie Wong, MD MPH is an assistant professor of surgery at Â鶹AV Medical School and a breast surgical oncologist at the JGH Segal Cancer Centre in Montreal, Canada. She received her medical degree and completed general surgery residency at Â鶹AV, her MPH at the Harvard School of Public Health, and in 2019, completed a breast surgical oncology fellowship at Dana-Farber/Brigham and Women’s Cancer Centre and Massachusetts General Hospital. Her clinical and research interests focus on surgical outcomes following neoadjuvant treatment and high-risk patient populations. She directs the High Risk Breast Clinic at the JGH Stroll Cancer Prevention Centre. In 2021, she was the recipient of the FRQS Chercheurs Boursiers Cliniciens award for research on Optimizing Surgical Decision Making and Prevention Strategies for Women at Elevated Breast Cancer Risk.

Selected publications: 

Golshan M, Loibl S, Wong SM, Huober JB, O’Shaughnessy J, Rugo HS, Wolmark N, McKee M, Maag D, Sullivan DM, Metzger-Filho O, Von Minckwitz G, Geyer CE, Sikov WM, Untch M. Breast Conservation after Neoadjuvant Chemotherapy for Triple Negative Breast Cancer: Surgical Results from an International Randomized Trial (BrighTNess). JAMA Surg. 2020 Mar 1;155(3):e195410.

Wong SM, Almana N, Choi J, Hu J, Gagnon H, Natsuhara K, Shen A, DeSantis S, Dominici L, Golshan M, Weiss A, Bellon J, Mittendorf EA, King TA. Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells after Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Onc, 2019 Jun 21. doi: 10.1245/s10434-019-07517-2.

Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer. Ann Surg 2017; 265(3):581-589.

Wong SM, King TA, Boileau JF, Barry WT, Golshan MA. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma in situ. Ann Surg Onc 2017 Sep;24(9):2509-2517.

Wong SM, Stout NK, Punglia R, Prakash I, Sagara Y, Golshan M. Breast Cancer Prevention Strategies in Lobular Carcinoma in Situ: A Decision Analysis. Cancer 2017 Jul 15;123(14):2609-2617.

Sagara Y, Freedman RA, Vaz-Luis I, Mallory MA, Wong SM, Aydogan F, DeSantis B, Barry WT, Golshan M. Patient Prognostic Score and Associations with Survival Improvement Offered by Radiotherapy After Breast Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study. J Clin Oncol. 2016; 34(11):1190-6.

Back to top